IGFBP4 anticorps (C-Term)
-
- Antigène Voir toutes IGFBP4 Anticorps
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
-
Épitope
- C-Term
-
Reactivité
- Humain, Souris, Boeuf (Vache)
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp IGFBP4 est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Séquence
- KGELDCHQLA DSFRE
- Purification
- Affinity purification
- Immunogène
- C-terminal
- Isotype
- IgG
- Top Product
- Discover our top product IGFBP4 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin. Aliquot and store at -20 °C. Minimize freezing and thawing.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
-
- Antigène
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
- Autre désignation
- IGFBP4 (IGFBP4 Produits)
- Synonymes
- anticorps IGFBP4, anticorps igfbp4, anticorps BP-4, anticorps HT29-IGFBP, anticorps IBP4, anticorps IGFBP-4, anticorps AI875747, anticorps Deb2, anticorps IGF-BP4, anticorps IBP-4, anticorps insulin like growth factor binding protein 4, anticorps insulin-like growth factor-binding protein 4, anticorps insulin-like growth factor binding protein 4, anticorps IGFBP4, anticorps LOC100136305, anticorps LOC100194498, anticorps igfbp4, anticorps Igfbp4
- Pathways
- Signalisation WNT, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process
-